合成路线1
该中间体在本合成路线中的序号:
(A) The condensation of 1-ethyl-5-aminopyrazole (I) with diethyl ethoxymethylenemalonate (II) by heating at 120 C gives diethyl [((1-ethyl-5-pyrazolyl)amino)methylene]malonate (III), which by heating at 235-5 C in diphenyl ether is converted into ethyl 1-ethyl-4-hydroxy-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (IV). The reaction of (IV) with ethyl iodide (A) and K2CO3 in DMF affords ethyl 1-ethyl-4-ethoxy-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (V), which is condensed with hydrazine in refluxing ethanol with ZnCl2 yielding ethyl 1-ethyl-4-hydrazino-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (VI). Finally, (VI) is condensed with refluxing acetone (B).
【1】
Hoehn, H.; Chasin, M. (Bristol-Myers Squibb Co.); Hydrazines and hydrazones of pyrazolopyridine carboxylic acids and esters. DE 2028869; GB 1317797; NL 165461C; NL 7008768 .
|
【2】
Chatterjee, S.S.; Etazolate. Drugs Fut 1977, 2, 4, 243.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(B) |
23199 |
2-Propanone; Acetone; beta-ketopropane; chevron acetone;propan-2-one; Dimethyl formaldehyde; Dimethyl ketone; dimethylketal; Ketone propane; Methyl ketone; Propanone; Pyroacetic acid; Pyroacetic ether |
67-64-1 |
C3H6O |
详情 | 详情
|
(I) |
40098 |
1-ethyl-1H-pyrazol-5-amine; 1-ethyl-1H-pyrazol-5-ylamine
|
3528-58-3 |
C5H9N3 |
详情 | 详情
|
(II) |
14088 |
Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate
|
87-13-8 |
C10H16O5 |
详情 | 详情
|
(III) |
40099 |
diethyl 2-[[(1-ethyl-1H-pyrazol-5-yl)amino]methylene]malonate
|
|
C13H19N3O4 |
详情 |
详情
|
(IV) |
40100 |
ethyl 1-ethyl-4-hydroxy-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
|
|
C11H13N3O3 |
详情 |
详情
|
(V) |
40101 |
ethyl 4-ethoxy-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
|
|
C13H17N3O3 |
详情 |
详情
|
(VI) |
40102 |
ethyl 1-ethyl-4-hydrazino-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
|
|
C11H15N5O2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) Several methods for obtaining this compoud have been described:
1) By treating the 4-isobutyl phenyl acetonitrile (I) with sodium amide and ethyl iodide, followed by the hydrolysis of the reaction product (II).
2) The reaction of the nitrile (I) with sodium ethoxide and diethyl carbonate leads to the cyanoacetic ester (III), which is treated with ethyl iodide; thus (IV) being obtained, the hydrolysis and decarboxylation of (IV) leads to the final acid.
3) The alkaline hydrolysis of the 4-isobutyl phenyl acetonitrile (I) leads to 4-isobutyl phenyl acetic acid (V). This product after treatment with Na in naphthalene and ethyl iodide (A) yields the required compound.
【1】
Aparicio, L.; et al.; Procedimiento para la obtencion del acido 2-(4'-isobutifenil)butirico. ES 427197; ES 435173; ES 435174 .
|
【2】
Aparicio, L.; Butibufen. Drugs Fut 1977, 2, 3, 156.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(I) |
33614 |
2-(4-isobutylphenyl)acetonitrile
|
|
C12H15N |
详情 |
详情
|
(II) |
33615 |
2-(4-isobutylphenyl)butanenitrile
|
|
C14H19N |
详情 |
详情
|
(III) |
33616 |
ethyl 2-cyano-2-(4-isobutylphenyl)acetate
|
|
C15H19NO2 |
详情 |
详情
|
(IV) |
33617 |
ethyl 2-cyano-2-(4-isobutylphenyl)butanoate
|
|
C17H23NO2 |
详情 |
详情
|
(V) |
33618 |
2-(4-isobutylphenyl)acetic acid
|
|
C12H16O2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(X) 2) Hexadeuteroethyl alcohol (IX) is treated with red phosphorus and I2 at reflux temperature to give pentadeuteroethyl iodide (X), which is condensed with potassium phthalimide (XI) in DMF, yielding N-(pentadeuteroethyl)phthalimide (XII). The hydrolysis of (XII) with hydrazine and HCl affords pentadeuteroethylamine (XIII), which is condensed with 1-methylpiperidin-4-one (III) and formaldehyde (XIV) in a Mannich reaction to give 3-methyl-7-(pentadeuteroethyl)-3,7-diazabicyclo[3.3.1]nonan-9-one (XV). The reduction of (XV) with NaBH4 as before yields the diastereomeric mixture (XVI + XVII). Finally, the alpha-isomer (XVI) is condensed with 4-chlorobenzoyl chloride (VIII) as before to give the pentadeuterium-labeled bisaramil.
【1】
Mlinko, S.; Simon Trompler, E.; Szammer, J.; Synthesis of bisaramil labelled with carbon-14 and deuterium. J Label Compd Radiopharm 1994, 34, 4, 313.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
10919 |
1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one |
1445-73-4 |
C6H11NO |
详情 | 详情
|
(VIII) |
10295 |
p-Chlorobenzoyl chloride; 4-Chlorobenzoyl chloride
|
122-01-0 |
C7H4Cl2O |
详情 | 详情
|
(IX) |
10924 |
Ethyl alcohol; Ethanol
|
1516-08-1 |
C2H6O |
详情 | 详情
|
(IX) |
44687 |
Ethanol-d6
|
|
C2H6O |
详情 |
详情
|
(X) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(X) |
44688 |
1-iodoethane-d5
|
|
C2H5I |
详情 |
详情
|
(XI) |
10926 |
(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)potassium
|
|
C8H4KNO2 |
详情 |
详情
|
(XII) |
10927 |
2-Ethyl-1H-isoindole-1,3(2H)-dione
|
5022-29-7 |
C10H9NO2 |
详情 | 详情
|
(XII) |
44689 |
2-ethyl-1H-isoindole-1,3(2H)-dione
|
|
C10H9NO2 |
详情 |
详情
|
(XIII) |
10928 |
Ethanamine
|
75-04-7 |
C2H7N |
详情 | 详情
|
(XIII) |
44690 |
ethylamine; 1-ethanamine
|
|
C2H7N |
详情 |
详情
|
(XV) |
10929 |
3-Ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-one
|
|
C10H18N2O |
详情 |
详情
|
(XV) |
44691 |
3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-one
|
|
C10H18N2O |
详情 |
详情
|
(XVI) |
10921 |
3-Ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol
|
|
C10H20N2O |
详情 |
详情
|
(XVI) |
44692 |
3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol
|
|
C10H20N2O |
详情 |
详情
|
(XVII) |
10922 |
3-Ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol
|
|
C10H20N2O |
详情 |
详情
|
(XVII) |
44693 |
3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]nonan-9-ol
|
|
C10H20N2O |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(A) 2) The condensation of quinoline (IX) with piperazine (XI) by heating at 140 C as before gives 1-cyclopropyl-6-fluoro-7-(1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-3-carboxylic acid (XII), which is finally treated with ethyl iodide and triethylamine in hot DMF.
【1】
Grohe, K.; Petersen, U.; Kuck, K.-H. (Bayer AG); Antimicrobial agent of quinolone-carboxylic acid b. DE 3248507; US 4563459 .
|
【2】
Grohe, K.; Klimetzek, V.; Metzger, K.G.; Stunkel, K.G.; Zeiler, H.-J. (Bayer AG); Immunostimulant agent. AU 8542762; DE 3420116; EP 0165474; ES 8607020; JP 1985258163; US 4659603 .
|
【3】
Castaner, J.; Prous, J.; Enrofloxacin. Drugs Fut 1988, 13, 4, 305.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(IX) |
22101 |
7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
|
86393-33-1 |
C13H9ClFNO3 |
详情 | 详情
|
(XI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(XII) |
22103 |
1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
|
85721-33-1 |
C17H18FN3O3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(IV) 3-Phenyl-5-aminopyrazole (I) is reacted with sodium formylacetate (III) to give (II). Alkylation ot (II) with ethyl iodide (IV) in DMF solution in the presence ot K2CO3 gives the target compound.
【1】
Pirisino, R.; Pecori-Vettori, L.; Ceppateli, P.; Corrias, M.; Mangano, G.; Ignesti, G.; Carla, V.; Further investigation on the antiinflammatory acti. Pharm Sci 1981, 36, 682.
|
【2】
Pecori-Vettori, L.; Pirisino, R.; Ignesti, G.; Bruni, F.; Auzzi, G.; Raimondi, L.; Banchelli, G.; Costanzo, A.; Corrias, M.; Cecci, L.; 2-Phenylpirazolo[1-5-a]pyrimidin-7-ones. A new cla. J Med Chem 1983, 26, 1706.
|
【3】
Pirisino, R.; Messori, A.; Auzzi, G.; Bruni, F.; Pecori-Vettori, L.; Costanzo, A.; Cecchi, L.; FPP-028. Drugs Fut 1987, 12, 4, 345.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22906 |
3-phenyl-1H-pyrazol-5-amine; 3-phenyl-1H-pyrazol-5-ylamine
|
827-41-8 |
C9H9N3 |
详情 | 详情
|
(II) |
22907 |
2-phenylpyrazolo[1,5-a]pyrimidin-7(4H)-one
|
|
C12H9N3O |
详情 |
详情
|
(III) |
28397 |
sodium 3-oxopropanoate
|
|
C3H3NaO3 |
详情 |
详情
|
(IV) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The alkylation of L-proline (I) with ethyl iodide (II) and K2CO3 gives N-ethylproline ethyl ester (III), which is treated with ammonia in methanol to afford N-ethyl-L-prolinamide (IV). The reduction of (IV) with LiAlH4 yields (S)-1-ethylpyrrolidin-2-ylmethylamine (V), which is condensed with 3-bromo-2,5,6-trimethoxybenzoyl chloride (VI) to provide the corresponding amide (VII). Finally, this compound is partially demethylated with BBr3 to provide the target compound.
【1】
Hogberg, M.; Novel substituted salicylamides and benzamides as selective dopamine D2-receptor antagonists. Drugs Fut 1991, 16, 4, 333.
|
【2】
Ramsby, S.; Hogberg, T.; Strom, P.; Efficient stereoconservative syntheses of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines. Acta Chem Scand 1989, 43, 660-664.
|
【3】
Hogberg, T.; Ramsby, S.; Strom, P.; Ebner, M.; Cyanide as an efficient and mild catalyst in the aminolysis of esters. J Org Chem 1987, 52, 2033-2036.
|
【4】
Hogberg, T.; et al.; Potential antipsychotic agents. 5. Synthesis and antidopaminergic properties of substituted 5, 6-dimethoxysalicylamides and related compounds. J Med Chem 1990, 33, 1155-63.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16731 |
L-proline
|
147-85-3 |
C5H9NO2 |
详情 | 详情
|
(II) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(III) |
42895 |
ethyl (2S)-1-ethyl-2-pyrrolidinecarboxylate
|
|
C9H17NO2 |
详情 |
详情
|
(IV) |
42896 |
(2S)-1-ethyl-2-pyrrolidinecarboxamide
|
55446-83-8 |
C7H14N2O |
详情 | 详情
|
(V) |
21345 |
(2S)-1-Ethyl-2-(aminomethyl)pyrrolidine; [(2S)-1-Ethylpyrrolidinyl]methanamine
|
|
C7H16N2 |
详情 |
详情
|
(VI) |
42897 |
3-bromo-2,5,6-trimethoxybenzoyl chloride
|
|
C10H10BrClO4 |
详情 |
详情
|
(VII) |
42898 |
3-bromo-N-[[(2S)-1-ethylpyrrolidinyl]methyl]-2,5,6-trimethoxybenzamide
|
|
C17H25BrN2O4 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The alkylation of L-proline (I) with ethyl iodide (II) and K2CO3 gives N-ethylproline ethyl ester (III), which is treated with ammonia in methanol to afford N-ethyl-L-prolinamide (IV). The reduction of (IV) with LiAlH4 yields (S)-1-ethylpyrrolidin-2-ylmethylamine (V), which is condensed with 3-iodo-2,5,6-trimethoxybenzoyl chloride (VI) to provide the corresponding amide (VII). Finally, this compound is partially demethylated with BBr3 to provide the target compound.
【1】
Hogberg, T.; Ramsby, S.; Strom, P.; Ebner, M.; Cyanide as an efficient and mild catalyst in the aminolysis of esters. J Org Chem 1987, 52, 2033-2036.
|
【2】
Ramsby, S.; Hogberg, T.; Strom, P.; Efficient stereoconservative syntheses of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines. Acta Chem Scand 1989, 43, 660-664.
|
【3】
Hogberg, M.; Novel substituted salicylamides and benzamides as selective dopamine D2-receptor antagonists. Drugs Fut 1991, 16, 4, 333.
|
【4】
Hogberg, T.; et al.; Potential antipsychotic agents. 5. Synthesis and antidopaminergic properties of substituted 5, 6-dimethoxysalicylamides and related compounds. J Med Chem 1990, 33, 1155-63.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16731 |
L-proline
|
147-85-3 |
C5H9NO2 |
详情 | 详情
|
(II) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(III) |
42895 |
ethyl (2S)-1-ethyl-2-pyrrolidinecarboxylate
|
|
C9H17NO2 |
详情 |
详情
|
(IV) |
42896 |
(2S)-1-ethyl-2-pyrrolidinecarboxamide
|
55446-83-8 |
C7H14N2O |
详情 | 详情
|
(V) |
21345 |
(2S)-1-Ethyl-2-(aminomethyl)pyrrolidine; [(2S)-1-Ethylpyrrolidinyl]methanamine
|
|
C7H16N2 |
详情 |
详情
|
(VI) |
42906 |
3-iodo-2,5,6-trimethoxybenzoyl chloride
|
|
C10H10ClIO4 |
详情 |
详情
|
(VII) |
42907 |
N-[[(2S)-1-ethylpyrrolidinyl]methyl]-3-iodo-2,5,6-trimethoxybenzamide
|
|
C17H25IN2O4 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(VI) The condensation of 4-hydroxy-6-methyl-2H-pyran-2-one (I) with 1-phenyl-1-propanol (II) by means of TsOH in toluene gives 4-hydroxy-6-methyl-3-(1-phenyl-propyl)-2H-pyran-2-one (III), which is alkylated with benzyl bromide and LDA in THF yielding 4-hydroxy-6-(2-phenylethyl)-3-(1-phenylpropyl)-2H-pyran-2-one (V). Finally this compound is submitted to a new alkylation process with ethyl iodide and LDA in THF to afford the target compound.
【1】
Romines, K.R.; Thaisrivongs, S.; Analogs of 4-hydroxypyrone: potent, non-peptidic HIV protease inhibitors. Drugs Fut 1995, 20, 4, 377.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41231 |
4-hydroxy-6-methyl-2H-pyran-2-one
|
675-10-5 |
C6H6O3 |
详情 | 详情
|
(II) |
41232 |
1-phenyl-1-propanol
|
|
C9H12O |
详情 |
详情
|
(III) |
41233 |
4-hydroxy-6-methyl-3-(1-phenylpropyl)-2H-pyran-2-one
|
|
C15H16O3 |
详情 |
详情
|
(IV) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(V) |
41234 |
4-hydroxy-6-phenethyl-3-(1-phenylpropyl)-2H-pyran-2-one
|
|
C22H22O3 |
详情 |
详情
|
(VI) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
Quaternization of 4-pyridylcarbinol (I) by means of iodoethane provided pyridinium salt (II), which was reduced with NaBH4 to the tetrahydropyridine (III). Subsequent Mitsunobu coupling of (III) with 1-acetyl-6-bromo-2,3-dihydro-1H-indol-5-ol (IV) afforded ether (V). Intramolecular cyclization of (V) to the spiro compound (VI) was effected by treatment with tributyltin hydride and azobis(isobutyronitrile). The acetamide function of (VI) was then hydrolyzed by refluxing with HCl in H2O-EtOH to furnish intermediate diamine (VII).
【1】
Gaster, L.M.; King, F.D.; Wyman, P.A. (GlaxoSmithKline plc); Tetracyclic spiro cpds., process for their preparation and their use as 5HT1D receptor antagonists. EP 0799226; JP 1998510821; US 5972951; WO 9619477 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(I) |
32835 |
4-pyridinylmethanol
|
586-95-8 |
C6H7NO |
详情 | 详情
|
(II) |
32836 |
1-ethyl-4-(hydroxymethyl)pyridinium iodide
|
|
C8H12INO |
详情 |
详情
|
(III) |
32837 |
(1-ethyl-1,2,3,6-tetrahydro-4-pyridinyl)methanol
|
|
C8H15NO |
详情 |
详情
|
(IV) |
19324 |
1-(6-bromo-5-hydroxy-2,3-dihydro-1H-indol-1-yl)-1-ethanone
|
|
C10H10BrNO2 |
详情 |
详情
|
(V) |
32838 |
1-[6-bromo-5-[(1-ethyl-1,2,3,6-tetrahydro-4-pyridinyl)methoxy]-2,3-dihydro-1H-indol-1-yl]-1-ethanone
|
|
C18H23BrN2O2 |
详情 |
详情
|
(VI) |
32839 |
1'-Ethyl-3,5,6,7-tetrahydro-2H-spiro[furo[2,3-f]indole-3,4'-piperidine]; 5-Acetyl-1'-ethyl-3,5,6,7-tetrahydro-2H-spiro[furo[2,3-f]indole-3,4'-piperidine]
|
|
C18H24N2O2 |
详情 |
详情
|
(VII) |
32844 |
1'-Ethyl-3,5,6,7-tetrahydro-2H-spiro[furo[2,3-f]indole-3,4'-piperidine]
|
|
C16H22N2O |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
The reaction of 2,6-di(tert-butyl)phenol (I) with CS2 and ethyl chloroacetate gives the dithiobenzoate (II), which is treated with hydrazine in ethanol yielding the thiobenzoyl hydrazide (III). The cyclization of (III) with CS2 in refluxing ethanol affords the thiadiazolethione (IV), which is finally condensed with ethyl iodide and NaOH in THF.
【1】
Sercel, A.D.; Connor, D.T.; Song, Y.; et al.; Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series. J Med Chem 1999, 42, 7, 1161. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
|
16601 |
ethyl chloroacetate; ethyl 2-chloroacetate
|
105-39-5 |
C4H7ClO2 |
详情 | 详情
|
(I) |
25925 |
2,6-di(tert-butyl)phenol
|
128-39-2 |
C14H22O |
详情 | 详情
|
(II) |
25926 |
ethyl 2-[[3,5-di(tert-butyl)-4-hydroxybenzothioyl]sulfanyl]acetate
|
|
C19H28O3S2 |
详情 |
详情
|
(III) |
25927 |
3,5-di(tert-butyl)-4-hydroxybenzenecarbothiohydrazide
|
|
C15H24N2OS |
详情 |
详情
|
(IV) |
25928 |
5-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione
|
|
C16H22N2OS2 |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
The Grignard reaction of 1-(tert-butoxycarbonyl)piperidin-4-one (I) with 3-fluorophenylmagnesium bromide (II) in THF gives the tertiary alcohol (III), which is dehydrated with TFA or HCl in dioxane yielding the tetrahydropyridine (IV). The condensation of (IV) with 2,4-dichloro-6-methylpyrimidine (V) by means of DIEA in ethanol affords 2-chloro-4-[4-(3-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl]-6-methylpyrimidine (VI), which is further condensed with 4-isopropyl-2-(methylsulfanyl)aniline (VII) by means of DIEA in refluxing ethylene glycol to give the secondary amine (VIII). Finally, this compound is alkylated with ethyl iodide and NaH in DMF.
【1】
Chaki, S.; Nakazato, A.; Okubo, T.; Kumagai, T.; Tomisawa, K.; Okuyama, S.; CRF1 receptor antagonists: Aryl-1,2,3,6-tetrahydropyridinopyrimidine derivatives. Symp Med Chem 1998, Abst 1-P-26.
|
【2】
Okubo, T.; Tanaka, H.; Chaki, S.; Okuyama, S.; Tomisawa, K.; Kumagai, T.; Nakazato, A.; Design, synthesis and structure-affinity relationships of 4-methylidenepiperidine and 4-aryl-1,2,3,6-tetrahydropyridine derivatives as corticotropin-releasing factor1 receptor antagonists. Bioorg Med Chem 2000, 8, 5, 1183. |
【3】
Okubo, T.; Okuyama, S.; Nakazato, A.; Tomisawa, K.; Aibe, I.; Chaki, S.; Kumagai, T.; Tanaka, H. (Taisho Pharmaceutical Co., Ltd.); 4-Tetrahydropyridylpyrimidine derivs.. EP 0976745; JP 1999228568; WO 9842699 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(I) |
18620 |
tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone |
79099-07-3 |
C10H17NO3 |
详情 | 详情
|
(II) |
35384 |
bromo(3-fluorophenyl)magnesium
|
|
C6H4BrFMg |
详情 |
详情
|
(III) |
35385 |
tert-butyl 4-(3-fluorophenyl)-4-hydroxy-1-piperidinecarboxylate
|
|
C16H22FNO3 |
详情 |
详情
|
(IV) |
35386 |
4-(3-fluorophenyl)-1,2,3,6-tetrahydropyridine
|
|
C11H12FN |
详情 |
详情
|
(V) |
35387 |
2,4-dichloro-6-methylpyrimidine
|
5424-21-5 |
C5H4Cl2N2 |
详情 | 详情
|
(VI) |
35388 |
2-chloro-4-[4-(3-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]-6-methylpyrimidine
|
|
C16H15ClFN3 |
详情 |
详情
|
(VII) |
35389 |
4-isopropyl-2-(methylsulfanyl)phenylamine; 4-isopropyl-2-(methylsulfanyl)aniline
|
|
C10H15NS |
详情 |
详情
|
(VIII) |
35390 |
N-[4-[4-(3-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]-6-methyl-2-pyrimidinyl]-N-[4-isopropyl-2-(methylsulfanyl)phenyl]amine; 4-[4-(3-fluorophenyl)-3,6-dihydro-1(2H)-pyridinyl]-N-[4-isopropyl-2-(methylsulfanyl)phenyl]-6-methyl-2-pyrimidinamine
|
|
C26H29FN4S |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
The Grignard reaction of 1-(tert-butoxycarbonyl)piperidin-3-one (I) with 2-methylphenylmagnesium bromide (II) in THF gives the tertiary alcohol (III), which is dehydrated with TFA or HCl in dioxane yielding the tetrahydropyridine (IV). The condensation of (IV) with 2,4-dichloro-6-methylpyrimidine (V) by means of DIEA in ethanol affords 2-chloro-6-methyl-4-[3-(2-methylphenyl)-1,2,3,6-tetrahydropyridin-1-yl]pyrimidine (VI), which is further condensed with 4-isopropyl-2-(methylsulfanyl)aniline (VII) by means of DIEA in refluxing ethylene glycol to give the secondary amine (VIII). Finally, this compound is alkylated with ethyl iodide and NaH in DMF.
【1】
Chaki, S.; Nakazato, A.; Okubo, T.; Kumagai, T.; Tomisawa, K.; Okuyama, S.; CRF1 receptor antagonists: Aryl-1,2,3,6-tetrahydropyridinopyrimidine derivatives. Symp Med Chem 1998, Abst 1-P-26.
|
【2】
Okubo, T.; Okuyama, S.; Nakazato, A.; Tomisawa, K.; Aibe, I.; Chaki, S.; Kumagai, T.; Tanaka, H. (Taisho Pharmaceutical Co., Ltd.); 4-Tetrahydropyridylpyrimidine derivs.. EP 0976745; JP 1999228568; WO 9842699 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(I) |
18620 |
tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone |
79099-07-3 |
C10H17NO3 |
详情 | 详情
|
(II) |
35391 |
bromo(2-methylphenyl)magnesium
|
|
C7H7BrMg |
详情 |
详情
|
(III) |
35392 |
tert-butyl 3-hydroxy-3-(2-methylphenyl)-1-piperidinecarboxylate
|
|
C17H25NO3 |
详情 |
详情
|
(IV) |
35393 |
5-(2-methylphenyl)-1,2,3,6-tetrahydropyridine
|
|
C12H15N |
详情 |
详情
|
(V) |
35387 |
2,4-dichloro-6-methylpyrimidine
|
5424-21-5 |
C5H4Cl2N2 |
详情 | 详情
|
(VI) |
35394 |
2-chloro-4-methyl-6-[5-(2-methylphenyl)-3,6-dihydro-1(2H)-pyridinyl]pyrimidine
|
|
C17H18ClN3 |
详情 |
详情
|
(VII) |
35389 |
4-isopropyl-2-(methylsulfanyl)phenylamine; 4-isopropyl-2-(methylsulfanyl)aniline
|
|
C10H15NS |
详情 |
详情
|
(VIII) |
35395 |
N-[4-isopropyl-2-(methylsulfanyl)phenyl]-4-methyl-6-[5-(2-methylphenyl)-3,6-dihydro-1(2H)-pyridinyl]-2-pyrimidinamine; N-[4-isopropyl-2-(methylsulfanyl)phenyl]-N-[4-methyl-6-[5-(2-methylphenyl)-3,6-dihydro-1(2H)-pyridinyl]-2-pyrimidinyl]amine
|
|
C27H32N4S |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(A) The reduction of 2-nitro-4,5-methylenedioxyacetophenone (I) with H2 over PtO2 in ethanol gives 2-amino-4,5-methylenedioxyacetophenone (II), which is cyclized by treatment with NaNO2 and HCl in water yielding 6,7-methylenedioxycinnolin-4-ol (III). The bromination of (III) with Br2 and potassium acetate in refluxing acetic acid affords 3-bromo-6,7-methylenedioxycinnolin-4-ol (IV), which is treated with Cu2(CN)2 in refluxing DMF giving 4-hydroxy-6,7-methylenedioxycinnolin-3-carbonitrile (V). Alkylation of (V) with ethyl iodide (A) by means of NaH in DMF affords 1-ethyl-6,7-methylenedioxy-4(1H)-oxocinnolin-3-carbonitrile (VI), which is finally hydrolyzed with HCl in refluxing acetic acid.
【1】
Roberts, P.J.; Castañer, J.; Cinoxacin. Drugs Fut 1978, 3, 1, 22.
|
【2】
Un metodo para la preparacion de acidos 6,7-metilendioxi-4(1H)-oxocinnolin-3-carboxilicos. ES 376173; ES 402312 .
|
【3】
Maas, I.M. Pfeiffer, W.G.; Voithenleitner, F.; 1-niederalkyl- oder -alkylensubstituierte 6,7-Methylendioxyd-4(1H)-oxocinnolin-3-carbosauren und Zwiswhenprodukte dafur. DE 2005104; FR 2034519; GB 1296753; GB 1296754 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(I) |
39691 |
1-(6-nitro-1,3-benzodioxol-5-yl)-1-ethanone
|
56136-84-6 |
C9H7NO5 |
详情 | 详情
|
(II) |
18886 |
1-(6-amino-1,3-benzodioxol-5-yl)-1-ethanone
|
28657-75-2 |
C9H9NO3 |
详情 | 详情
|
(III) |
39692 |
[1,3]dioxolo[4,5-g]cinnolin-4-ol
|
|
C9H6N2O3 |
详情 |
详情
|
(IV) |
39693 |
3-bromo[1,3]dioxolo[4,5-g]cinnolin-4-ol
|
|
C9H5BrN2O3 |
详情 |
详情
|
(V) |
39694 |
4-hydroxy[1,3]dioxolo[4,5-g]cinnoline-3-carbonitrile
|
|
C10H5N3O3 |
详情 |
详情
|
(VI) |
39695 |
1-ethyl-4-oxo-1,4-dihydro[1,3]dioxolo[4,5-g]cinnoline-3-carbonitrile
|
|
C12H9N3O3 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(IV) Condensation between dichloropurine (I) and substituted aniline (II) in pentanol affords derivative (III), which is then alkylated with ethyl iodide (IV) by means of Cs2CO3 in DMF to provide purine (V). Finally, the desired compound is obtained by attack of amine (VI) and displacement of the chlorine atom of derivative (V) in diglyme.
【1】
Bruggen, J.; Caravatti, G.; Capraro, H.-G.; et al.; Chemistry and biological characterization of CGP79807, a highly selective CDK1/2 inhibitor. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 150.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25254 |
2,6-dichloro-9H-purine
|
5451-40-1 |
C5H2Cl2N4 |
详情 | 详情
|
(II) |
28662 |
3-aminobenzonitrile
|
2237-30-1 |
C7H6N2 |
详情 | 详情
|
(III) |
48922 |
3-[(2-chloro-9H-purin-6-yl)amino]benzonitrile
|
|
C12H7ClN6 |
详情 |
详情
|
(IV) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(V) |
48923 |
3-[(2-chloro-9-ethyl-9H-purin-6-yl)amino]benzonitrile
|
|
C14H11ClN6 |
详情 |
详情
|
(VI) |
19581 |
trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; |
27489-62-9 |
C6H13NO |
详情 | 详情
|
合成路线15
该中间体在本合成路线中的序号:
(II) Treatment of methyl pyrrole-2-carboxylate (I) with KOtBu and 18-crown-6 in Et2O, followed by reaction with ethyl iodide (II) in Et2O, yields methyl 1-ethylpyrrole-2-carboxylate (III), which is then subjected to saponification with NaOH to afford carboxylic acid (IV). Condensation of (IV) with beta-alanine benzyl ester p-toluene sulfonate (V) in the presence of diethyl phosphorocyanidate (DEPC) and Et3N in DMF provides benzyl ester (VI), which is then hydrogenated over Pd/C in THF, furnishing carboxylic acid (VII). Cyclization of (VII) with polyphosphoric acid (PPA) affords derivative (VIII), which is then treated with NaH in DMF and alkylated with chloro derivative (IX) in DMF to produce compound (X). Finally, treatment of (X) with hydroxylamine hydrochloride and NaOAc affords the target compound.
【1】
Mizuno, A.; Miya, M.; Inomata, N.; Tatsuoka, T.; Ishihara, T. (Suntory Ltd.); Pyrroloazepine cpd.. EP 0557526; JP 1993503481; US 5399557; WO 9303032 .
|
【2】
Yamaki, A.; Tatsuoka, T.; Miya, M.; Nakanishi, K.; Mizuno, A.; Takiguchi, C.; Hidaka, T.; Kamei, T.; Shibata, M.; Inomata, N.; Studies on antihypertensive agents with antithrombotic activity. 2. Syntheses and pharmacological evaluation of pyrrolo[2,3-c]azepine derivatives. Chem Pharm Bull 2000, 48, 8, 1129. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
45616 |
methyl 1H-pyrrole-2-carboxylate
|
|
C6H7NO2 |
详情 |
详情
|
(II) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(III) |
45617 |
methyl 1-ethyl-1H-pyrrole-2-carboxylate
|
|
C8H11NO2 |
详情 |
详情
|
(IV) |
45618 |
1-ethyl-1H-pyrrole-2-carboxylic acid
|
|
C7H9NO2 |
详情 |
详情
|
(V) |
30194 |
benzyl 3-aminopropanoate
|
27019-47-2 |
C10H13NO2 |
详情 | 详情
|
(VI) |
45619 |
benzyl 3-[[(1-ethyl-1H-pyrrol-2-yl)carbonyl]amino]propanoate
|
|
C17H20N2O3 |
详情 |
详情
|
(VII) |
45620 |
N-[(1-ethyl-1H-pyrrol-2-yl)carbonyl]-beta-alanine
|
|
C10H14N2O3 |
详情 |
详情
|
(VIII) |
45621 |
1-ethyl-6,7-dihydropyrrolo[2,3-c]azepine-4,8(1H,5H)-dione
|
|
C10H12N2O2 |
详情 |
详情
|
(IX) |
45622 |
1-(3-chloropropyl)-4-(4-fluorophenyl)piperazine
|
|
C13H18ClFN2 |
详情 |
详情
|
(X) |
45623 |
1-ethyl-7-[3-[4-(4-fluorophenyl)-1-piperazinyl]propyl]-6,7-dihydropyrrolo[2,3-c]azepine-4,8(1H,5H)-dione
|
|
C23H29FN4O2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(II) 2-Mercapto-4-quinazolone (I) is treated with ethyl iodide (II) in the presence of sodium ethoxide to yield 2-ethylthio-4-quinazolone (III). Reaction of (III) with N-benzylpiperazine (IV) to give (V) and followed by catalytic debenzylation with H2 over Pd/C in glacial acetic acid affords Centpiperalone.
【1】
Gupta, C.M.; Muscimol analogs. II. Synthesis of some bicyclic 3-isoxazolol zwitterions. Med Chem 1968, 11, 3, 392.
|
【2】
Arya, V.P.; Centpiperalone. Drugs Fut 1979, 4, 8, 557.
|
【3】
Gupta, C.M.; et al.; Resveratrol regulates IGF-II in MCF-7 human breast cancer cells. Ind J Chem 1971, 9, 3, 201.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61384 |
2-Mercapto-4(3H)-quinazolinone
2-Thio-4(3H)-quinazolinone; 2-Mercapto-4(3H)-quinazolinone
2-Thio-4(3H)-quinazolinone
|
13906-09-7 |
C8H6N2OS |
详情 | 详情
|
(II) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(III) |
61385 |
2-(ethylsulfanyl)-4(3H)-quinazolinone
|
|
C10H10N2OS |
详情 |
详情
|
(IV) |
28542 |
N-Benzylpiperazine; 1-Benzylpiperazine
|
2759-28-6 |
C11H16N2 |
详情 | 详情
|
(V) |
61386 |
2-(4-benzyl-1-piperazinyl)-4(3H)-quinazolinone
|
|
C19H20N4O |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(XII) Friedel–Crafts acylation of 2-tert-butylphenol (I) with acetyl chloride (II) in the presence of AlCl3 in cold toluene gives 1-(3-tert-butyl-4-hydroxyphenyl)ethanone (III) (1, 2), which by nitration with HNO3 in cold H2O/CH2Cl2 provides 1-(3-tert-butyl-4-hydroxy-5-nitrophenyl)ethanone (IV). O-Alkylation of phenol (IV) with methyl iodide by means of K2CO3 in DMF produces the methyl ether (V), which is reduced at the nitro group with Fe and NH4Cl in EtOH/H2O to afford the corresponding amine (VI). Cyclocondensation of the aniline derivative (VI) with bis(2-bromoethyl) ether (VII) by means of NaI and K2CO3 in DMF provides the 3-morpholino-acetophenone derivative (VIII). α-Halogenation of acetophenone (VIII) with NBS by means of Et3N and TBDMSOTf in THF yields the corresponding bromoacetophenone (IX) , which is finally condensed with isoindole derivative (X) in THF or DMF .
The isoindole intermediate (X) is prepared by dialkylation of 3-fluorocatechol (XI) with ethyl iodide (XII) in the presence of K2CO3 in DMF to give 1,2-diethoxy-3-fluorobenzene (XIII), which is brominated with Br2 by means of NaOAc in AcOH at 70 °C to yield 1,2-dibromo-4,5-diethoxy-3-fluorobenzene (XIV). Bromide substitution in intermediate (XIV) with CuCN in DMF at 150 °C affords 4,5-diethoxy-3-fluorophthalonitrile (XV), which is finally submitted to reductive cyclization with H2 over PtO2 in EtOAc/EtOH/MeOH .
【1】
Suzuki, S., Naoe, Y., Miyamoto, M. et al. (Eisai R&D Management Co., Ltd.). 2-Iminopyrrolidine derivatives. EP 1391451, EP 2385039, US 2005004204, US 7244730, WO 2002085855. |
【2】
Shimomura, N., Sasho, M., Kayano, A., Yoshizawa, K., Tsujii, M., Kuroda,H., Furukawa, K. (Eisai R&D Management Co., Ltd.). Processes for producing cyclic benzamidine derivative. CA 2515715, EP 1602646, US 2006058370, US 7375236, WO 2004078721. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
67678 |
2-tert-butylphenol;o-t-Butylphenol;o-tert-Butylphenol;2-tert-Butyl-1-hydroxybenzene;2-(1,1-Dimethylethyl)phenol |
88-18-6 |
C10H14O |
详情 | 详情
|
(II) |
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
(III) |
68400 |
1-(3-tert-butyl-4-hydroxyphenyl)ethanone |
|
C12H16O2 |
详情 | 详情
|
(IV) |
68401 |
1-(3-(tert-butyl)-4-hydroxy-5-nitrophenyl)ethanone |
|
C12H15NO4 |
详情 | 详情
|
(V) |
68402 |
1-(3-(tert-butyl)-4-methoxy-5-nitrophenyl)ethanone |
|
C13H17NO4 |
详情 | 详情
|
(VI) |
68403 |
1-(3-amino-5-(tert-butyl)-4-methoxyphenyl)ethanone |
|
C13H19NO2 |
详情 | 详情
|
(VII) |
63502 |
1-bromo-2-[(2-bromoethyl)oxy]ethane; bis(2-bromoethyl) ether
|
5414-19-7 |
C4H8Br2O |
详情 | 详情
|
(VIII) |
68404 |
1-(3-(tert-butyl)-4-methoxy-5-morpholinophenyl)ethanone |
|
C17H25NO3 |
详情 | 详情
|
(IX) |
68405 |
2-bromo-1-(3-(tert-butyl)-4-methoxy-5-morpholinophenyl)ethanone |
|
C17H24BrNO3 |
详情 | 详情
|
(X) |
68406 |
5,6-diethoxy-4-fluoro-1H-isoindol-3-amine |
|
C12H15FN2O2 |
详情 | 详情
|
(XI) |
68407 |
3-fluorocatechol;3-FLUORO-1,2-DIHYDROXYBENZENE;3-FLUOROBENZENE-1,2-DIOL;1-FLUORO-2,3-DIHYDROXYBENZENE;1,2-Dihydroxy-3-fluoroBenzene |
363-52-0 |
C6H5FO2 |
详情 | 详情
|
(XII) |
10925 |
Iodoethane;ethyl iod |
75-03-6 |
C2H5I |
详情 | 详情
|
(XIII) |
68408 |
1,2-diethoxy-3-fluorobenzene |
|
C10H13FO2 |
详情 | 详情
|
(XIV) |
68409 |
1,2-dibromo-4,5-diethoxy-3-fluorobenzene |
|
C10H11Br2FO2 |
详情 | 详情
|
(XV) |
68410 |
4,5-diethoxy-3-fluorophthalonitrile;6-(aminomethyl)-3,4-diethoxy-2-fluorobenzonitrile |
474554-45-5 |
C12H11FN2O2 |
详情 | 详情
|